{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:12:50Z","timestamp":1792534370038,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,4,21]],"date-time":"2015-04-21T00:00:00Z","timestamp":1429574400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00066-015-0837-z","type":"journal-article","created":{"date-parts":[[2015,4,20]],"date-time":"2015-04-20T06:50:02Z","timestamp":1429512602000},"page":"604-612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Long-term side effects of radiotherapy for pediatric localized neuroblastoma","Langzeittoxizit\u00e4t nach Strahlentherapie des lokalisierten Neuroblastoms im Kindesalter"],"prefix":"10.1007","volume":"191","author":[{"name":"On behalf of the Neuroblastoma study group and radiotherapy group of the French Society of Children with Cancer (SFCE)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Ducassou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Gambart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Munzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Carrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Haas-Kogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Bernier-Chastagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Demoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Claude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Helfre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Bolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Leseur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymeri","family":"Huchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Rubie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Valteau-Couanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Schleiermacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Coze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Defachelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Marabelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Ducassou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Devalck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Gandemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Munzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Laprie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,21]]},"reference":[{"key":"837_CR1","volume-title":"SEER Cancer Statistics Review, 1975\u20132010","author":"N Howlader","year":"2013","unstructured":"Howlader N, Noone AM, Krapcho M et al (2013) SEER Cancer Statistics Review, 1975\u20132010. National Cancer Institute, Bethesda"},{"key":"837_CR2","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.bjc.6604640","volume":"99","author":"BM Bernardi De","year":"2008","unstructured":"De Bernardi BM, Rubie H et al (2008) Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group. Br J Cancer 99:1027\u20131033","journal-title":"Br J Cancer"},{"key":"837_CR3","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1038\/bjc.1998.384","volume":"77","author":"H Rubie","year":"1998","unstructured":"Rubie H, Michon J, Plantaz D et al (1998) Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Oncologie P\u00e9diatrique (SFOP). Br J Cancer 77:2310\u20132317","journal-title":"Br J Cancer"},{"key":"837_CR4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/cncr.20453","volume":"101","author":"A Laprie","year":"2004","unstructured":"Laprie A, Michon J, Hartmann O et al (2004) High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification. Cancer 101:1089","journal-title":"Cancer"},{"key":"837_CR5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1200\/JCO.2008.17.9184","volume":"27","author":"R Bagatell","year":"2009","unstructured":"Bagatell R, Beck-Popovic M, London WB et al (2009) Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database. J Clin Oncol 27:365\u2013370","journal-title":"J Clin Oncol"},{"key":"837_CR6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1200\/JCO.1991.9.5.789","volume":"9","author":"RP Castleberry","year":"1991","unstructured":"Castleberry RP, Kun LE, Shuster JJ et al (1991) Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. J Clin Oncol 9:789\u2013795","journal-title":"J Clin Oncol"},{"key":"837_CR7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM199910143411601","volume":"341","author":"K Matthay","year":"1999","unstructured":"Matthay K, Villablanca J, Seeger R et al (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children\u2019s Cancer Group. N Engl J Med 341:1165\u20131173","journal-title":"N Engl J Med"},{"key":"837_CR8","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/jnci\/djp230","volume":"101","author":"C Laverdi\u00e8re","year":"2009","unstructured":"Laverdi\u00e8re C, Liu Q, Yasui Y et al (2009) Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 101:1131\u201311340","journal-title":"J Natl Cancer Inst"},{"key":"837_CR9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0360-3016(01)02713-4","volume":"52","author":"AC Paulino","year":"2002","unstructured":"Paulino AC, Mayr N, Simon JH et al (2002) Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity. Int J Radiat Oncol Biol Phys 52:1025\u20131031","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"837_CR10","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1200\/JCO.1997.15.3.1171","volume":"15","author":"H Rubie","year":"1997","unstructured":"Rubie H, Hartmann O, Michon J et al (1997) N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NB 90 study. Neuroblastoma Study Group of the Soci\u00e9t\u00e9 Francaise d\u2019Oncologie P\u00e9diatrique. J Clin Oncol 15:1171\u20131182","journal-title":"J Clin Oncol"},{"key":"837_CR11","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/sj.bjc.6601259","volume":"89","author":"H Rubie","year":"2003","unstructured":"Rubie H, Coze C, Plantaz D et al (2003) Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy. Br J Cancer 89:1605\u20131609","journal-title":"Br J Cancer"},{"key":"837_CR12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2307\/2530374","volume":"34","author":"RL Prentice","year":"1978","unstructured":"Prentice RL, Kalbfleisch JD, Peterson AV Jr et al (1978) The analysis of failure times in the presence of competing risks. Biometrics 34:541\u2013554","journal-title":"Biometrics"},{"key":"837_CR13","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","volume":"355","author":"KC Oeffinger","year":"2006","unstructured":"Oeffinger KC, Mertens AC, Sklar CA et al (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572\u20131582","journal-title":"N Engl J Med"},{"key":"837_CR14","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.ijrobp.2008.10.069","volume":"74","author":"HG Gatcombe","year":"2009","unstructured":"Gatcombe HG, Marcus RB Jr, Katzenstein HM et al (2009) Excellent local control from radiation therapy for high-risk neuroblastoma. Int J Radiat Oncol Biol Phys 74:1549\u20131554","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"837_CR15","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/cncr.20091","volume":"100","author":"SM Bradfield","year":"2004","unstructured":"Bradfield SM, Douglas JG, Hawkins DS et al (2004) Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma. Cancer 100:1268\u20131275","journal-title":"Cancer"},{"key":"837_CR16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jpedsurg.2005.10.050","volume":"41","author":"M Browne","year":"2006","unstructured":"Browne M, Kletzel M, Cohn SL et al (2006) Excellent local tumor control regardless of extent of surgical resection after treatment on the Chicago Pilot II protocol for neuroblastoma. J Pediatr Surg 41:271\u2013276","journal-title":"J Pediatr Surg"},{"key":"837_CR17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/pbc.20331","volume":"45","author":"C Laverdi\u00e8re","year":"2005","unstructured":"Laverdi\u00e8re C, Cheung N-KV, Kushner BH et al (2005) Long-term complications in survivors of advanced stage neuroblastoma. Pediatr Blood Cancer 45:324\u2013332","journal-title":"Pediatr Blood Cancer"},{"key":"837_CR18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/pbc.23036","volume":"57","author":"T Perwein","year":"2011","unstructured":"Perwein T, Lackner H, Sovinz P et al (2011) Survival and late effects in children with stage 4 neuroblastoma. Pediatr Blood Cancer 57:629\u2013635","journal-title":"Pediatr Blood Cancer"},{"key":"837_CR19","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/bmt.2013.218","volume":"49","author":"LE Cohen","year":"2014","unstructured":"Cohen LE, Gordon JH, Popovsky EY et al (2014) Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: high incidence of endocrine and growth problems. Bone Marrow Transplant 49:502\u2013508","journal-title":"Bone Marrow Transplant"},{"key":"837_CR20","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/pbc.24452","volume":"60","author":"L Moreno","year":"2013","unstructured":"Moreno L, Vaidya SJ, Pinkerton CR et al (2013) Long-term follow-up of children with high-risk neuroblastoma: the ENSG5 trial experience. Pediatr Blood Cancer 60:1135\u20131140","journal-title":"Pediatr Blood Cancer"},{"key":"837_CR21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2106\/00004623-198163020-00002","volume":"63","author":"JK Mayfield","year":"1981","unstructured":"Mayfield JK, Riseborough EJ, Jaffe N et al (1981) Spinal deformity in children treated for neuroblastoma. J Bone Joint Surg 63:183\u2013193","journal-title":"J Bone Joint Surg"},{"key":"837_CR22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ijrobp.2004.07.719","volume":"61","author":"AC Paulino","year":"2005","unstructured":"Paulino AC, Fowler BZ (2005) Risk factors for scoliosis in children with neuroblastoma. Int J Radiat Oncol Biol Phys 61:865\u2013869","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"837_CR23","first-page":"3227","volume":"85","author":"C Sklar","year":"2000","unstructured":"Sklar C, Whitton J, Mertens A et al (2000) Abnormalities of the thyroid in survivors of Hodgkin\u2019s disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 85:3227\u20133232","journal-title":"J Clin Endocrinol Metab"},{"key":"837_CR24","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1200\/JCO.2008.21.1920","volume":"27","author":"AT Meadows","year":"2009","unstructured":"Meadows AT, Friedman DL, Neglia JP et al (2009) Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 27:2356\u20132362","journal-title":"J Clin Oncol"},{"key":"837_CR25","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/ijc.11455","volume":"107","author":"C Rubino","year":"2003","unstructured":"Rubino C, Adjadj E, Gu\u00e9rin S et al (2003) Long-term risk of second malignant neoplasms after neuroblastoma in childhood: role of treatment. Int J Cancer 107:791\u2013796","journal-title":"Int J Cancer"},{"key":"837_CR26","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2005.10.020","volume":"64","author":"I Flandin","year":"2006","unstructured":"Flandin I, Hartmann O, Michon J et al (2006) Impact of TBI on late effects in children treated by megatherapy for stage IV neuroblastoma. A study of the French Society of Pediatric oncology. Int J Radiat Oncol 64:1424\u20131431","journal-title":"Int J Radiat Oncol"},{"key":"837_CR27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1756-6649-12-2","volume":"12","author":"V Beneyton","year":"2012","unstructured":"Beneyton V, Niederst C, Vigneron C et al (2012) Comparison of the dosimetries of 3-dimensions radiotherapy (3D-RT) with linear accelerator and intensity modulated radiotherapy (IMRT) with helical tomotherapy in children irradiated for neuroblastoma. BMC Med Phys 12:2","journal-title":"BMC Med Phys"},{"key":"837_CR28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/pbc.20456","volume":"46","author":"AC Paulino","year":"2006","unstructured":"Paulino AC, Ferenci MS, Chiang K-Y et al (2006) Comparison of conventional to intensity modulated radiation therapy for abdominal neuroblastoma. Pediatr Blood Cancer 46:739\u2013744","journal-title":"Pediatr Blood Cancer"},{"key":"837_CR29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/pbc.21059","volume":"48","author":"AC Paulino","year":"2007","unstructured":"Paulino AC (2007) IMRT in abdominal neuroblastoma: response. Pediatr Blood Cancer 48:715","journal-title":"Pediatr Blood Cancer"},{"key":"837_CR30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2217\/fon.12.199","volume":"9","author":"JE Gains","year":"2013","unstructured":"Gains JE, Stacey C, Rosenberg I et al (2013) Intensity-modulated arc therapy to improve radiation dose delivery in the treatment of abdominal neuroblastoma. Future Oncol 9:439\u2013449","journal-title":"Future Oncol"},{"key":"837_CR31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/pbc.22649","volume":"56","author":"R Shaffer","year":"2011","unstructured":"Shaffer R, Vollans E, Vellani R et al (2011) A radiotherapy planning study of RapidArc, intensity modulated radiotherapy, three-dimensional conformal radiotherapy, and parallel opposed beams in the treatment of pediatric retroperitoneal tumors. Pediatr Blood Cancer 56:16\u201323","journal-title":"Pediatr Blood Cancer"},{"key":"837_CR32","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/pbc.24606","volume":"60","author":"C Hill-Kayser","year":"2013","unstructured":"Hill-Kayser C, Tochner Z, Both S et al (2013) Proton versus photon radiation therapy for patients with high-risk neuroblastoma: the need for a customized approach. Pediatr Blood Cancer 60:1606\u20131611","journal-title":"Pediatr Blood Cancer"},{"key":"837_CR33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.radonc.2008.06.012","volume":"89","author":"M Hillbrand","year":"2008","unstructured":"Hillbrand M, Georg D, Gadner H et al (2008) Abdominal cancer during early childhood: a dosimetric comparison of proton beams to standard and advanced photon radiotherapy. Radiother Oncol 89:141\u2013149","journal-title":"Radiother Oncol"},{"key":"837_CR34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0360-3016(02)04506-6","volume":"56","author":"DA Haas-Kogan","year":"2003","unstructured":"Haas-Kogan DA, Swift PS, Selch M et al (2003) Impact of radiotherapy for high-risk neuroblastoma: a Children\u2019s Cancer Group study. Int J Radiat Oncol Biol Phys 56:28\u201339","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"837_CR35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00066-006-1498-8","volume":"182","author":"T Simon","year":"2006","unstructured":"Simon T, Hero B, Bongartz R et al (2006) Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children >\u20091 year with residual local disease. Strahlenther Onkol 182:389\u2013394","journal-title":"Strahlenther Onkol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-015-0837-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-015-0837-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-015-0837-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T16:25:47Z","timestamp":1566577547000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-015-0837-z"}},"subtitle":["Results from clinical trials NB90 and NB94","Ergebnisse der NB90- und NB94-Studien"],"short-title":[],"issued":{"date-parts":[[2015,4,21]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["837"],"URL":"https:\/\/doi.org\/10.1007\/s00066-015-0837-z","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,21]]}}}